Skip to main content

Where Will Jim Thome Land?


Some folks around baseball have felt throughout the offseason that Jim Thome would inevitably return to the Chicago White Sox and resume his duties as the team's designated hitter. Thome was traded by the ChiSox prior to last year's trading deadline to the Dodgers for minor league infielder Justin Fuller and cash. Thome appeared only as a pinch hitter for the Dodgers, down the stretch last year, and he managed to get just 5 singles in 20 at bats, including the post season.

Thome stated to Chicago reporters, at a White Sox charity function on Wednesday, that he'd come back to the White Sox if they called and wanted him. But, keeping things real, Thome added, "I want to play baseball. Right now, we're talking to a few teams, so we'll see what happens. It's been a slow winter in the market, so we're waiting to see what's going to happen and move forward."

So, what teams might Thome be negotiating with? Not the White Sox!

Chicago manager Ozzie Guillen spoke about the situation on Thursday. Guillen told the media, "Nobody is a bigger Jim Thome fan than me. But in the meantime, (Thome's departure) gives this ball club an opportunity to give more people more at bats and to be flexible in different ways."

Guillen also stated that other White Sox players, namely Mark Kotsay, Andruw Jones, Paul Konerko, Omar Vizquel and Carlos Quentin could potentially see time as the team's designated hitter.

"To me, it's easier and we get more production with the team we have now that way, Gullien added."

With full time DH's virtually at an all time low (only Boston with David Ortiz and Cleveland with Travis Hafner have DH's who don't also play a defensive position), Thome, who is unable to play the field very well, if at all due to health issues, may find it very difficult to find a job.

Thome is 39 years old and is 12th all time on the MLB homerun leaders list. I am sure there are teams who are, or will be, interested, but it remains to be seen who they might be and what money they might offer Thome.

------------------------------------
Follow PhoulBallz.com on Twitter HERE for unique trivia, stats, our "Name that Phillies Autograph" game and updates!

BallHype: hype it up!

Comments

Popular posts from this blog

What the hell else was I going to write about...?

It will be too late for many people's liking, but it's really about time to NEVER USE BRAD LIDGE IN A SAVE SITUATION ON THE ROAD AGAIN. Lidge in 2009 road games- 0-6, 8.10 ERA, 15 saves, 10 blown saves. One of my favorite statistics that I regularly update here on PhoulBallz is the percentage of games that Brad Lidge has allowed earned runs in this season, compared to the 18% he allowed in 2008. This year, Lidge has allowed earned runs in 43% of his outings. And, as a reminder, in 2007 Brett Myers allowed earned runs in just 21% of his relief appearances. Considering Lidge's season-long struggles, what is the solution when Brett Myers is ailing with a back muscle/shoulder injury, when Chan Ho Park has an injured hamstring, when Ryan Madson looks just as inept in the 9th inning as Brad Lidge seems and when JC Romero is still unavailable to pitch due to a forearm injury? Well, on Wednesday night, with Hanley Ramirez batting with two outs and the tying run on 3rd base, your an...

More headline entertainment

CBS3.com has enlightened the Phillies world to the genius that is new GM Ruben Amaro Jr. In the steal of the century, the Phils have apparently signed outfielder Jayson Werth to a $10 contract. Wow! If you catch this soon enough the headline blunder is still there, but if not, here's a screen capture of the dealio.

Romero Settlement "Validates" Phils' Title

Back in 2008, Phillies lefty reliever J.C. Romero tested positive for banned substances and was subsequently suspended for the first 50 games of the 2009 season. Some felt the findings in Romero's test tainted the World Series victory by Philadelphia that year. Romero contested that he had only used supplements purchased at local vitamin chains and the companies responsible for those items should be held accountable for mislabeling their products. Romero took his issues to court, filing lawsuits in New Jersey Superior Court in early 2009 that named GNC and Vitamin Shoppe as defendants in addition to the manufacturing companies, Ergopharm and Proviant Technologies. According to the NY Daily News , testing done on the vitamins revealed that they were tainted with the banned substance, androstenedione, that Romero tested positive for. This month, nearly three years later, Romero has reached a settlement, which Romero hopes will clear his name and provide closure for Philadelphia...